Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Data from University of Washington provide new insights into cancer vaccines
April 16th, 2008
According to recent research published in the journal Clinical Lung Cancer, "Active tumor immunotherapy may provide hope for patients with non-small-cell lung cancer (NSCLC) because, in more than 20 years, current therapies have yet to change mortality statistics. Creating an efficacious vaccine involves selection of important tumor antigens and formulation of their immunogenic epitopes into a construct for delivery to antigen-presenting cells." "The method of immunization will confer significant properties to the potency of the vaccine and might require augmentation with certain adjuvant agents like interieukin-12 and granulocyte-macrophage colony-stimulating...
Source: Vaccine Weekly (2008-04-16)
|
